NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

The Medtronic Symplicty Spyral renal denervation ... The approvals reflect CMS’s recognition of these devices as breakthrough technologies representing significant clinical advances in managing ...

Medtronic acquired the Sphere-9 catheter for pulsed field ablation (PFA), radiofrequency (RF) ablation and cardiac mapping in its 2022 purchase of device developer Affera for up to $1 billion. In 2023 ...

Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions. The Total REALITY study retrospectively compared ...

Medtronic plc develops, manufactures ... and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and ...

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...